James M. Anderson - 26 Jan 2022 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role
Director
Signature
/s/ F. Mark Reuter as Attorney-in-Fact for James M. Anderson
Issuer symbol
N/A
Transactions as of
26 Jan 2022
Net transactions value
$0
Form type
4
Filing time
28 Jan 2022, 10:32:21 UTC
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Award $0 +3,012 +18% $0.000000 19,724 26 Jan 2022 Direct F1
holding VIVO Common Stock 5,000 26 Jan 2022 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVO Stock Options (Right to Buy) Award $0 +5,656 $0.000000 5,656 26 Jan 2022 Common Stock 5,656 $20.75 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.
F2 These options are awarded under the 2021 Omnibus Award Plan and vest in full (100%) on January 25, 2023.